최진영 원장 2025 Korea EVO ICL FORUM 초청강연_ 'ICL수술 10년 장기적 임상결과'

최진영 원장 2025 Korea EVO ICL FORUM 초청강연_ 'ICL수술 10년 장기적 임상결과'

2025.07.11 2924

아이리움안과 최진영 대표원장이

지난 7월 5일 서울에서 개최된

2025 Korea EVO ICL FORUM에 초청,

ICL 렌즈의 장기적 임상결과를 강연했습니다.

DATE
July 5, 2025
TIME
6:30PM
LOCATION
Josun Palace The Great Hall
Long-Term Clinical Outcomes Of ICL(V4c vs V4)- Literature based Review
Jin Young Choi, M.D. EYEREUM EYE CLINIC, Seoul, Republic of Korea. Program Date 2025.7.5
2025 KOREA EVO ICL FORUM

2025 KOREA EVO ICL FORUM
DATE
July 5, 2025
TIME
6:30 PM
LOCATION
Josun Palace, The Great Hall
Ten-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics
PURPOSE: This study aimed to evaluate the long-term clinical outcomes of V4c Implantable Collamer Lens (ICL) implantation for myopia correction over a 10-year period.
METHODS: This retrospective interventional case series included 102 eyes from 56 patients. Visual outcomes, including visual acuity and manifest refraction were assessed. Annual measurements of endothelial cell density (ECD), vault, anterior chamber depth, and intraocular pressure were analyzed using mixed-effects models.
RESULTS: At the 10-year follow-up, the mean logarithm of the Minimum Angle of Resolution (logMAR) uncorrected distance visual acuity and corrected distance visual acuity (CDVA) were 0.02 ± 0.13 and -0.08 ± 0.08, respectively. The mean efficacy and safety indices were 1.01 ± 0.21 and 1.22 ± 0.17. A loss of one line of CDVA occurred in 2% of cases, while 98% gained one or more lines. Postoperative manifest refraction spherical equivalent (MRSE) was within ±0.5 diopters (D) and ±1.0 D in 74% and 99% of cases, respectively, with a mean MRSE of -0.19 ± 0.41 D. Data for ECD and vault in an exponential decay model, demonstrating a stabilization rate gradually slowing down over time. Mean ECD was 2642 ± 245 cells/mm² for ECD and 416 ± 188 μm for vault. The results for ECD and vault...
4c ICL 수술 후 10년간 변화 임상 결과
EYE CLINIC

이날 강연은 아이리움안과의 ICL 10년 임상결과 SCI 논문,

AJO (American Journal of Ophthalmology)에 게재된
‘10-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics’

내용을 중심으로 진행됐습니다.

해당 연구는 수술 후 10년간의 시력, 각막내피세포 및 렌즈 위치(Vault) 등

장기 추적 관찰을 포함했습니다.

DATE.
July 5, 2025
TIME.
6:30PM
LOCATION.
Josun Palace The Great Hall
A. Uncorrected Distance Visual Acuity
Visual Acuity (20/x or better) Postop UDVA Preop CDVA
20/12.5 1% 0%
20/16 53% 2%
20/20 97% 97%
20/25 100% 100%
Cumulative Snellen Visual Acuity (20/x or better)
B. Change in Corrected Distance Visual Acuity
Change in Snellen Lines of CDVA % of Eyes
Loss 3 or More 0.0%
Loss 2 0.0%
Loss 1 2%
No Change 39%
Gain 1 55%
Gain 2 4%
Gain 3 or More 0%
2 or more lines lost: 0%
C. Spherical Equivalent Attempted vs Achieved
y = 0.9557x - 0.2413, R² = 0.9725. mean: -9.32 ± 2.37 D, range: -3.00 to -15.87 D. Labels: Overcorrected, Undercorrected.
D. Spherical Equivalent Refractive Accuracy
Postoperative Spherical Equivalent Refraction (D) % of Eyes
-2.00 to -1.51 1%
-1.50 to -1.01 1%
-1.00 to -0.51 24%
-0.50 to -0.14 26%
-0.13 to +0.13 27%
+0.14 to +0.50 20%
+0.51 to +1.00 1%
+1.01 to +1.50 0%
+1.51 to +2.00 0%
> +2.00 0%
±0.50 D: 74%, ±1.00 D: 99%
E. Refractive Astigmatism
Refractive Astigmatism (D) Postop % of Eyes Preop % of Eyes
≤ 0.25 9% 12%
0.26 to 0.50 27% 9%
0.51 to 0.75 7% 26%
0.76 to 1.00 13% 11%
1.01 to 1.25 11% 4%
1.26 to 1.50 13% 1%
1.51 to 2.00 22% 13%
2.01 to 3.00 0% 13%
≤0.50 D: 28%, ≤1.00 D: 82%
F. Stability of Spherical Equivalent Refraction
Time After Surgery (years) Mean ± SD Spherical Equivalent Refraction (D)
Preop -9.32
1 -0.05
2 -0.08
3 -0.10
5 -0.14
10 -0.19
% changed > 0.50 D in 10 years: 4%

Visual Acuity (20/x or better)	Postop UDVA	Preop CDVA
20/12.5	1%	0%
20/16	53%	2%
20/20	97%	97%
20/25	100%	100%

Change in Snellen Lines of CDVA	% of Eyes
Loss 3 or More	0.0%
Loss 2	0.0%
Loss 1	2%
No Change	39%
Gain 1	55%
Gain 2	4%
Gain 3 or More	0%

Postoperative Spherical Equivalent Refraction (D)	% of Eyes
-2.00 to -1.51	1%
-1.50 to -1.01	1%
-1.00 to -0.51	24%
-0.50 to -0.14	26%
-0.13 to +0.13	27%
+0.14 to +0.50	20%
+0.51 to +1.00	1%
+1.01 to +1.50	0%
+1.51 to +2.00	0%
> +2.00	0%

Refractive Astigmatism (D)	Postop % of Eyes	Preop % of Eyes
≤ 0.25	9%	12%
0.26 to 0.50	27%	9%
0.51 to 0.75	7%	26%
0.76 to 1.00	13%	11%
1.01 to 1.25	11%	4%
1.26 to 1.50	13%	1%
1.51 to 2.00	22%	13%
2.01 to 3.00	0%	13%

Time After Surgery (years)	Mean ± SD Spherical Equivalent Refraction (D)
Preop	-9.32
1	-0.05
2	-0.08
3	-0.10
5	-0.14
10	-0.19

최 원장은 이 강연에서 ICL 렌즈삽입술의 효과성과 장기적인 안정성,

그리고 관련 국제논문들이 갖는 학술적 의미에 대해 심도 있게 설명했습니다.

2025 KOREA EVO ICL FORUM
EVO ICL WOOJEON

2025 KOREA EVO ICL FORUM
WOOJEON
Presentation Slide Content
Key Discussion Points
평생토록 내피 밀도를 평가 할때에 고려할 점은?
Vaulting을 논할 때에는 CLR (Crystalline Lens Rise) 고려해서 생각해야 함.
Ophthalmol Ther. 2024
The Distribution of Crystalline Lens Rise in High Myopia Population and Its Influence on Vault After Implanting Intraocular Collamer Lens
Date
Jun 5, 2024
Venue
Grand InterContinental Seoul Parnas, Rose Room

또한 이날 포럼에서 최진영 원장은

ICL 렌즈의 임상 성과 및 학술적 기여를 인정받아, 미국 STAAR Surgical의 CMO인 Dr. Scott Barnes로부터 ‘ICL Expert Instructor’ 상패를 수여 받았습니다.

2025 KOREA EVO ICL FORUM
July 5, | Josun Palace Great Hall
Event Partners
STAAR SURGICAL
WOOJEON
EVO+ ICL™

Dr. Scott Barnes 역시 ICL을 집도하는 안과전문의로, 포럼 공식 강연 일정 이후

아이리움안과 본원을 직접 방문하여

최진영 원장을 포함한 아이리움안과 의료진들과 지견을 나누고,

수술 및 진료 환경을 견학했습니다.

강연 말미에 최진영 원장은 포럼에 참석한 안과 전문의들에게 다음과 같은 점을 강조했습니다.

“ICL은 우수하고 결과가 좋은 렌즈지만, 장기적이고 안정적이기 위해 계측 장비의 발전 속도에 맞춰 의사들은 철저한 검사로 수술에 적합한 눈을 정확히 선별하고, 환자에게 지속적인 정기 검진의 중요성을 교육할 수 있어야 합니다.
우리의 수술은 완벽할 수 있어도, 환자의 생활까지 통제할 수는 없기 때문입니다.”

아이리움안과는 앞으로도 과학적 근거에 기반한 진료와 지속적인 연구를 통해

더 나은 의료를 제공하기 위해 끊임없이 노력하겠습니다.